1010446-29-3 Usage
Uses
Used in Pharmaceutical Synthesis:
tert-butyl 3-(4-benzylpiperazin-1-yl)pyrrolidine-1-carboxylate is used as an intermediate in the synthesis of 3-(Piperazin-1-yl)pyrrolidine-1-carboxylic Acid tert-Butyl Ester (P479915). tert-butyl 3-(4-benzylpiperazin-1-yl)pyrrolidine-1-carboxylate is a key component in the development of new pharmaceutical agents with potential therapeutic applications.
Used in Drug Discovery:
tert-butyl 3-(4-benzylpiperazin-1-yl)pyrrolidine-1-carboxylate can also be used in the synthesis of a novel series of indazoles as ketohexokinase inhibitors. These indazoles have been shown to possess lead-like properties and good pharmaceutical characteristics, making them promising candidates for further drug development and optimization.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, tert-butyl 3-(4-benzylpiperazin-1-yl)pyrrolidine-1-carboxylate serves as a valuable building block for the design and synthesis of new bioactive molecules. Its unique structural features allow for the exploration of various chemical modifications and the evaluation of its potential as a therapeutic agent in different disease areas.
Overall, tert-butyl 3-(4-benzylpiperazin-1-yl)pyrrolidine-1-carboxylate is a versatile and important compound in the realm of pharmaceutical chemistry, with applications in drug synthesis, discovery, and research. Its unique properties and potential as a building block for new drug development make it a valuable asset in the ongoing pursuit of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1010446-29-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,0,4,4 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1010446-29:
(9*1)+(8*0)+(7*1)+(6*0)+(5*4)+(4*4)+(3*6)+(2*2)+(1*9)=83
83 % 10 = 3
So 1010446-29-3 is a valid CAS Registry Number.
1010446-29-3Relevant academic research and scientific papers
SUBSTITUTED BENZIMIDAZOLONE DERIVATIVES, MEDICAMENTS COMPRISING THEM AND THEIR USE
-
Page/Page column 96, (2008/06/13)
The present invention relates to novel benzimidazolone derivatives of the general formula (I) in which the substituents R1, R2, R3, A1, A2, and B are as defined in claim 1, medicaments comprising these, and the use thereof for the prophylaxis and/or treatment of vasopressin-dependent diseases.
